This graphic highlights just how system-wide their effects really are The Upside (why everyone is paying attention): Metabolic control Insulin secretion Glucagon Glucose uptake (muscle, adipose) Hepatic glucose production Weight loss drivers Gastric emptying earlier satiety Appetite (central nervous system) Lipolysis & thermogenesis Cardiorenal benefits Cardioprotection Diuresis/natriuresis Improved lipid & fatty acid metabolism Potential neurological benefits Signals around neuroprotection, synaptic function, and motor activity The Tradeoffs (often under-discussed): GI tolerability Slowed motility nausea, bloating, constipation Muscle & lean mass considerations Weight loss isnt purely fat risk of lean mass loss without intervention Pancreatic biology Chronic -cell stimulation + remodeling dynamics still being studied System-wide modulation These are not targeted drugs, they actually alter multiple organ systems simultaneously Long-term unknowns Especially around chronic use in non-diabetic, younger populations Any we've missed here

or are allergic to any of the ingredients in CONTRAVE
So when someone says, GLP-1s cause muscle loss, the first question should be: what exactly was measured
The areas attracting the most focused attention include inflammatory bowel disease, where the preclinical evidence base is deepest
Gastrointestinal Protective Properties Because the original protein is naturally found in gastric juices, BPC-157 demonstrates strong stability and potential regulatory behavior in: gut mucosal lining models cellular defence assays oxidative damage studies intestinal epithelial repair models Many research papers focus specifically on BPC-157s role in gastrointestinal integrity
Loren Pickart and is believed to play roles in tissue repair, inflammation control, and oxidative stress balance. Its levels decline with age, which is part of why its being studied for anti-aging and regenerative applications